当前位置:首页 - 行情中心 - 济川药业(600566) - 财务分析

济川药业

(600566)

  

流通市值:255.88亿  总市值:256.74亿
流通股本:9.18亿   总股本:9.21亿

济川药业(600566)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润10.24亿元,每股收益1.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1385776.46万元,未分配利润928608.18万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1653353.15万元,负债267576.69万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入3,932,057,245.532,748,717,966.211,525,389,316.38,016,894,756.63
营业总成本2,887,618,682.392,042,988,755.571,106,091,598.545,388,666,480.38
其他经营收益
营业利润1,255,128,353.42833,428,316.11502,324,358.52,862,889,616.44
利润总额1,260,406,214.76849,042,833.53514,669,004.462,978,246,258.99
净利润1,024,117,001.86725,285,908.9441,292,666.662,536,706,331.49
每股收益
其他综合收益----
综合收益总额1,024,117,001.86725,285,908.9441,292,666.662,536,706,331.49
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计12,945,450,807.2213,038,414,389.8514,637,024,658.9214,702,020,835.04
非流动资产:
非流动资产合计3,588,080,734.593,637,620,941.83,696,472,919.443,757,473,071.42
资产总计16,533,531,541.8116,676,035,331.6518,333,497,578.3618,459,493,906.46
流动负债:
流动负债合计2,431,672,741.262,948,868,339.352,966,636,587.833,538,200,163.2
非流动负债:
非流动负债合计244,094,172.91195,227,324.53199,563,460.58194,867,404.54
负债合计2,675,766,914.173,144,095,663.883,166,200,048.413,733,067,567.74
所有者权益(或股东权益):
归属于母公司股东权益合计13,829,413,055.7113,504,319,773.1115,141,767,178.414,701,852,749
股东权益合计13,857,764,627.6413,531,939,667.7715,167,297,529.9514,726,426,338.72
负债和股东权益合计16,533,531,541.8116,676,035,331.6518,333,497,578.3618,459,493,906.46
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计5,278,586,814.383,989,642,612.472,682,585,478.499,721,019,491.22
经营活动现金流出小计4,575,075,444.983,017,168,261.141,888,681,002.717,544,582,475.44
经营活动产生的现金流量净额703,511,369.4972,474,351.33793,904,475.782,176,437,015.78
投资活动产生的现金流量:
投资活动现金流入小计4,458,764,474.943,266,782,433.49917,852,231.985,119,418,946
投资活动现金流出小计5,021,530,152.234,242,820,725.86927,049,337.567,159,335,473.35
投资活动产生的现金流量净额-562,765,677.29-976,038,292.37-9,197,105.58-2,039,916,527.35
筹资活动产生的现金流量:
筹资活动现金流入小计763,658,197.31449,105,850.68283,631,958.411,441,663,600.75
筹资活动现金流出小计2,443,868,329.632,368,488,154.1322,581,170.932,646,804,155.55
筹资活动产生的现金流量净额-1,680,210,132.32-1,919,382,303.42-38,949,212.52-1,205,140,554.8
汇率变动对现金及现金等价物的影响-103.35--
现金及现金等价物净增加额-1,539,464,440.21-1,922,946,141.11745,758,157.68-1,068,620,066.37
期末现金及现金等价物余额5,129,898,303.54,746,416,602.67,415,120,901.396,669,362,743.71
补充资料:
现金及现金等价物的净增加额--1,922,946,141.11--1,068,620,066.37
最新报告期:2025-11-14
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华安证券谭国超1.782.002.302025-11-14
兴业证券孙媛媛,董晓洁,黄翰漾1.681.872.122025-11-04
TOP↑